Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12534438 | Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof | 🖼🧊📄§ | 2026-01-27 | 2041-12-15 | 0 | 31 |
| 12533415 | Core/shell structure platform for immunotherapy | 🖼🧊📄§ | 2026-01-27 | 2042-05-24 | 0 | 31 |
| 12533359 | Method for preventing hair loss | 🖼🧊📄§ | 2026-01-27 | 2040-07-02 | 0 | 31 |
| 12533373 | β-glucan composition and use therefor | 🖼🧊📄§ | 2026-01-27 | 2040-06-15 | 0 | 31 |
| 12533345 | Rufinamide for use in the treatment of myotonia | 🖼🧊📄§ | 2026-01-27 | 2044-05-22 | 0 | 31 |
| 12534709 | Shaped organoid compositions and methods of making same | 🖼🧊📄§ | 2026-01-27 | 2040-05-29 | 0 | 31 |
| 12534519 | Molecules for therapy and diagnosis | 🖼🧊📄§ | 2026-01-27 | 2040-04-17 | 0 | 31 |
| 12534517 | Highly specific zika neutralizing human antibodies | 🖼🧊📄§ | 2026-01-27 | 2038-11-21 | 0 | 31 |
| 12533348 | Ferroportin-inhibitors for the use in the treatment of transfusion-dependent beta-thalassemia (TDT) | 🖼🧊📄§ | 2026-01-27 | 2040-07-17 | 0 | 31 |
| 12533412 | Ultrasound-responsive liposome nanoparticles and preparation method and use thereof | 🖼🧊📄§ | 2026-01-27 | 2042-10-13 | 0 | 31 |
| 12534732 | Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell | 🖼🧊📄§ | 2026-01-27 | 2042-11-18 | 0 | 31 |
| 12533395 | Manipulation of meningeal lymphatic vasculature for brain and CNS tumor therapy | 🖼🧊📄§ | 2026-01-27 | 2039-11-15 | 0 | 31 |
| 12533396 | Compositions and methods for treating late-onset Pompe disease | 🖼🧊📄§ | 2026-01-27 | 2041-06-11 | 0 | 31 |
| 12533356 | Pyrazolopyrimidine compounds as adenosine receptor antagonists | 🖼🧊📄§ | 2026-01-27 | 2043-09-08 | 0 | 31 |
| 12533392 | Compositions and uses thereof | 🖼🧊📄§ | 2026-01-27 | 2037-05-17 | 0 | 31 |
| 12534537 | Anti-CD38 antibody and methods of use thereof | 🖼🧊📄§ | 2026-01-27 | 2040-06-26 | 0 | 31 |
| 12534538 | Anti-HER2 binding molecules | 🖼🧊📄§ | 2026-01-27 | 2040-03-20 | 0 | 31 |
| 12533408 | Treatment regimen for the treatment of autoimmune disorders | 🖼🧊📄§ | 2026-01-27 | 2044-06-20 | 0 | 31 |
| 12533363 | Methods and compositions for testosterone production | 🖼🧊📄§ | 2026-01-27 | 2045-05-22 | 0 | 31 |
| 12533343 | Method for preparing (−)-cibenzoline succinate | 🖼🧊📄§ | 2026-01-27 | 2039-09-20 | 0 | 31 |
| 12533372 | Biological polysaccharide for preventing and treating acne and steroid- dependent dermatitis and use thereof | 🖼🧊📄§ | 2026-01-27 | 2039-05-21 | 0 | 31 |
| 12533444 | Mitigation of peri-implantitis by design and stability of bifunctional peptides with antimicrobial properties | 🖼🧊📄§ | 2026-01-27 | 2040-09-07 | 0 | 31 |
| 12528865 | Treatment of lung cancer using a combination of an anti-PD-1 antibody and an anti-CTLA-4 antibody | 🖼🧊📄§ | 2026-01-20 | 2041-07-26 | 1 | 35 |
| 12527781 | Treatment of neurodegenerative conditions by disruption of Rhes | 🖼🧊📄§ | 2026-01-20 | 2040-10-30 | 0 | 31 |
| 12527836 | Gla domains as targeting agents | 🖼🧊📄§ | 2026-01-20 | 2040-12-18 | 0 | 31 |
| 12528864 | Antigen binding proteins | 🖼🧊📄§ | 2026-01-20 | 2042-09-02 | 0 | 31 |
| 12528858 | Humanized antibodies that recognize alpha-synuclein | 🖼🧊📄§ | 2026-01-20 | 2042-04-26 | 0 | 31 |
| 12527757 | Nanoemulsion of 18BETA-glycyrrhetinic acid | 🖼🧊📄§ | 2026-01-20 | 2040-08-07 | 0 | 31 |
| 12527776 | Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS) | 🖼🧊📄§ | 2026-01-20 | 2040-02-04 | 0 | 31 |
| 12527779 | Prostaglandin E2 (PGE2) EP4 receptor antagonists | 🖼🧊📄§ | 2026-01-20 | 2040-10-02 | 0 | 31 |
| 12527813 | Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides | 🖼🧊📄§ | 2026-01-20 | 2041-10-05 | 0 | 31 |
| 12527881 | Ionizable cationic lipid for RNA delivery | 🖼🧊📄§ | 2026-01-20 | 2041-04-19 | 0 | 31 |
| 12528848 | Tumor-specific neoantigens and methods of using the same | 🖼🧊📄§ | 2026-01-20 | 2039-05-28 | 0 | 31 |
| 12527851 | Methods and materials for treating cancer | 🖼🧊📄§ | 2026-01-20 | 2039-03-29 | 0 | 31 |
| 12527865 | haNK cetuximab combinations and methods | 🖼🧊📄§ | 2026-01-20 | 2042-09-01 | 0 | 31 |
| 12527819 | Method of preventing or treating viral infections | 🖼🧊📄§ | 2026-01-20 | 2041-04-14 | 0 | 31 |
| 12528872 | De novo binding domain containing polypeptides and uses thereof | 🖼🧊📄§ | 2026-01-20 | 2040-03-20 | 0 | 31 |
| 12528866 | Recombinant protein targeting PD-L1 and VEGF and compositions thereof | 🖼🧊📄§ | 2026-01-20 | 2042-05-05 | 0 | 31 |
| 12527823 | Generation of kidney glomerular specific endothelial cells and methods of use | 🖼🧊📄§ | 2026-01-20 | 2040-11-20 | 0 | 31 |
| 12527840 | Methods of treating fulminant viral hepatitis with an IL-18 antagonist in a patient with an IL-18BP variant | 🖼🧊📄§ | 2026-01-20 | 2040-06-04 | 0 | 31 |
| 12528851 | IL2-based therapeutics and methods of use thereof | 🖼🧊📄§ | 2026-01-20 | 2042-06-13 | 0 | 31 |
| 12527785 | Renin-angiotensin-aldosterone system (RAAS) inhibitors in the treatment of pancreatic ductal carcinoma | 🖼🧊📄§ | 2026-01-20 | 2043-01-10 | 0 | 31 |
| 12527842 | Composition for preventing or treating bone diseases comprising CCR2 | 🖼🧊📄§ | 2026-01-20 | 2039-11-15 | 0 | 31 |
| 12527729 | Minoxidil adjuvant therapies | 🖼🧊📄§ | 2026-01-20 | 2043-04-17 | 0 | 31 |
| 12527859 | Vaccine composition for chickenpox or Varicella Zoster and method of using same | 🖼🧊📄§ | 2026-01-20 | 2041-09-02 | 0 | 31 |
| 12528871 | Universal immune cells for cancer immunotherapy | 🖼🧊📄§ | 2026-01-20 | 2042-01-05 | 0 | 31 |
| 12527767 | Eye drops to treat chemically induced corneal damage | 🖼🧊📄§ | 2026-01-20 | 2043-12-20 | 0 | 31 |
| 12527788 | Defining RNA-small molecule affinity landscapes enables design of a small molecule inhibitor of an oncogenic non-coding RNA | 🖼🧊📄§ | 2026-01-20 | 2038-02-16 | 0 | 31 |
| 12529105 | Application of BAZ2B gene as target in slowing aging | 🖼🧊📄§ | 2026-01-20 | 2039-12-27 | 0 | 31 |
| 12528845 | Fish allergy antigen | 🖼🧊📄§ | 2026-01-20 | 2043-10-20 | 0 | 31 |